We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
-12.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$561M
AUM Growth
-$39.7M
Cap. Flow
+$40.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
31.65%
Holding
327
New
69
Increased
109
Reduced
108
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 10.38%
2 Financials 10.27%
3 Technology 9.96%
4 Consumer Discretionary 7.58%
5 Industrials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOOG icon
1
Vanguard S&P 500 Growth ETF
VOOG
$25.7B
$45.5M 8.1%
2,020,230
-254,004
-11% -$6.14M
VOOV icon
2
Vanguard S&P 500 Value ETF
VOOV
$6.58B
$41M 7.31%
420,366
-47,559
-10% -$5.02M
MDY icon
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$24.8M 4.42%
82,019
-5,550
-6% -$1.85M
VTV icon
4
Vanguard Value ETF
VTV
$186B
$14M 2.5%
143,114
+122,061
+580% +$12.8M
MSFT icon
5
Microsoft
MSFT
$2.93T
$10.9M 1.94%
107,038
+23,447
+28% +$2.51M
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$10.3M 1.83%
41,142
+28,786
+233% +$7.76M
JPM icon
7
JPMorgan Chase
JPM
$907B
$9M 1.6%
92,207
+6,703
+8% +$714K
VYM icon
8
Vanguard High Dividend Yield ETF
VYM
$80B
$8.62M 1.53%
+110,486
New +$9.22M
MCD icon
9
McDonald's
MCD
$190B
$6.86M 1.22%
38,641
+2,923
+8% +$518K
AMGN icon
10
Amgen
AMGN
$198B
$6.73M 1.2%
34,560
-1,288
-4% -$251K
HON icon
11
Honeywell
HON
$71.3B
$5.54M 0.99%
44,474
+713
+2% +$97.3K
KO icon
12
Coca-Cola
KO
$351B
$5.4M 0.96%
113,997
-11,259
-9% -$539K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.06T
$5.38M 0.96%
26,367
+5,570
+27% +$1.16M
MDT icon
14
Medtronic
MDT
$106B
$5.31M 0.95%
58,416
+26,518
+83% +$2.48M
SPYG icon
15
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.4B
$5.31M 0.95%
+163,344
New +$5.71M
ACWI icon
16
iShares MSCI ACWI ETF
ACWI
$32.8B
$4.87M 0.87%
75,930
-34,247
-31% -$2.35M
AAPL icon
17
Apple
AAPL
$4.9T
$4.8M 0.86%
121,836
+36,144
+42% +$1.75M
ABBV icon
18
AbbVie
ABBV
$450B
$4.78M 0.85%
51,821
-12,875
-20% -$1.13M
IVW icon
19
iShares S&P 500 Growth ETF
IVW
$73.1B
$4.6M 0.82%
122,024
-10,080
-8% -$408K
CSCO icon
20
Cisco
CSCO
$441B
$4.56M 0.81%
105,172
+15,357
+17% +$703K
INTC icon
21
Intel
INTC
$478B
$4.48M 0.8%
95,442
+6,072
+7% +$284K
JNJ icon
22
Johnson & Johnson
JNJ
$609B
$4.43M 0.79%
34,343
+10,416
+44% +$1.45M
VZ icon
23
Verizon
VZ
$182B
$4.42M 0.79%
78,562
-3,014
-4% -$171K
LMT icon
24
Lockheed Martin
LMT
$117B
$4.17M 0.74%
15,911
+185
+1% +$56.1K
HD icon
25
Home Depot
HD
$338B
$4.09M 0.73%
23,837
-2,006
-8% -$360K

Similar funds

Corient Capital Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Corient Capital Partners held 327 positions worth $561M, down 6.6% from $601M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Corient Capital Partners deployed $40.3M of net new capital in Q4 2018, opening 69 new positions and adding to 109 existing holdings. Its largest new stake was Vanguard High Dividend Yield ETF: 110,486 shares worth $8.62M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 10% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $6.14M trimmed.

  • Corient Capital Partners's largest Q4 2018 buy was Vanguard High Dividend Yield ETF: 110,486 shares worth $8.62M.
  • Corient Capital Partners added most to Vanguard Value ETF in Q4 2018, an estimated $12.8M increase.
  • Corient Capital Partners's biggest Q4 2018 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $6.14M.
  • Corient Capital Partners fully exited AES in Q4 2018, selling an estimated $4.07M.
  • Corient Capital Partners's ten largest holdings make up 32% of its $561M portfolio in Q4 2018.
  • Corient Capital Partners opened 69 new positions and closed 28 in Q4 2018.
  • Corient Capital Partners's portfolio value fell 6.6% quarter-over-quarter to $561M.

Based on Corient Capital Partners's 13F filing for Q4 2018, filed 7 Feb 2019.